Bayer Diagnostics says it is back in the game with a new generation of laboratory products
This article was originally published in Clinica
Executive Summary
Bayer is developing a new range of diagnostic products, which it says will bring flexibility and cost-savings to labs, as well as developing a secure revenue stream for the company. New self-testing procedures are also slated as important growth products, reports Martin Hedges, who went to Tarrytown, New York, to see Bayer Diagnostics at work.